Piper Jaffray Downgrades GHDX, Sees Regulatory Risk

March 6, 2006 7:16 AM EST Send to a Friend
Piper Jaffray downgrades Genomic Health (Nasdaq: GHDX) from Outperform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login